Evidence map›Paper›PMID 38368258›Full record

ArticleAdvanced science (Weinheim, Baden-Wurttemberg, Germany)2024

Self-Assembly of Heterogeneous Ferritin Nanocages for Tumor Uptake and Penetration.

Qiqi Liu, Chunyu Wang, Mingsheng Zhu, Jinming Liu, Qiannan Duan, Adam C Midgley, Ruming Liu, Bing Jiang, Deling Kong, Quan Chen and 2 more

Erratum issuedOpen access · goldAbstract read
In one paragraph

Article in Advanced science (Weinheim, Baden-Wurttemberg, Germany), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
2.8field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 16 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. A Purely Biomanufactured System for Delivering Nanoparticles and STING Agonists.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2025
    Article
  8. Self-Assembly of Heterogeneous Ferritin Nanocages for Tumor Uptake and Penetration.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2024
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

12 authors at 2 institutions in 1 country.

Qiqi LiuState Key Laboratory of Medicinal Chemical Biology, Key Laboratory of Bioactive Materials for the Ministry of Education, College of Life Sciences, and Frontier of Science Center for Cell Response, Nankai University, Tianjin, 300071, China.
Chunyu WangState Key Laboratory of Medicinal Chemical Biology, Key Laboratory of Bioactive Materials for the Ministry of Education, College of Life Sciences, and Frontier of Science Center for Cell Response, Nankai University, Tianjin, 300071, China.
Mingsheng ZhuState Key Laboratory of Medicinal Chemical Biology, Key Laboratory of Bioactive Materials for the Ministry of Education, College of Life Sciences, and Frontier of Science Center for Cell Response, Nankai University, Tianjin, 300071, China.
Jinming LiuState Key Laboratory of Medicinal Chemical Biology, Key Laboratory of Bioactive Materials for the Ministry of Education, College of Life Sciences, and Frontier of Science Center for Cell Response, Nankai University, Tianjin, 300071, China.
Qiannan DuanState Key Laboratory of Medicinal Chemical Biology, Key Laboratory of Bioactive Materials for the Ministry of Education, College of Life Sciences, and Frontier of Science Center for Cell Response, Nankai University, Tianjin, 300071, China.
Adam C MidgleyState Key Laboratory of Medicinal Chemical Biology, Key Laboratory of Bioactive Materials for the Ministry of Education, College of Life Sciences, and Frontier of Science Center for Cell Response, Nankai University, Tianjin, 300071, China.
Ruming LiuState Key Laboratory of Medicinal Chemical Biology, Key Laboratory of Bioactive Materials for the Ministry of Education, College of Life Sciences, and Frontier of Science Center for Cell Response, Nankai University, Tianjin, 300071, China.
Bing JiangNanozyme Medical Center, School of Basic Medical Sciences, Zhengzhou University, Zhengzhou, 450001, China.
Deling KongState Key Laboratory of Medicinal Chemical Biology, Key Laboratory of Bioactive Materials for the Ministry of Education, College of Life Sciences, and Frontier of Science Center for Cell Response, Nankai University, Tianjin, 300071, China.
Quan ChenState Key Laboratory of Medicinal Chemical Biology, Key Laboratory of Bioactive Materials for the Ministry of Education, College of Life Sciences, and Frontier of Science Center for Cell Response, Nankai University, Tianjin, 300071, China.
Jie ZhuangSchool of Medicine, Nankai University, Tianjin, 300071, China.
Xinglu HuangState Key Laboratory of Medicinal Chemical Biology, Key Laboratory of Bioactive Materials for the Ministry of Education, College of Life Sciences, and Frontier of Science Center for Cell Response, Nankai University, Tianjin, 300071, China.ORCID 0000-0002-9378-7425
Nankai University · CNZhengzhou University · CN

Funding

Nankai University Hundred Young Academic Leaders ProgramNational Key Research and Development Program of China 2022YFA1105100National Natural Science Foundation of China 32271448National Natural Science Foundation of China 82072054Tianjin Synthetic Biotechnology Innovation Capacity Improvement Project TSBICIP-KJGG-014-03
6 · The paper itself

Abstract

Well-defined nanostructures are crucial for precisely understanding nano-bio interactions. However, nanoparticles (NPs) fabricated through conventional synthesis approaches often lack poor controllability and reproducibility. Herein, a synthetic biology-based strategy is introduced to fabricate uniformly reproducible protein-based NPs, achieving precise control over heterogeneous components of the NPs. Specifically, a ferritin assembly toolbox system is developed that enables intracellular assembly of ferritin subunits/variants in Escherichia coli. Using this strategy, a proof-of-concept study is provided to explore the interplay between ligand density of NPs and their tumor targets/penetration. Various ferritin hybrid nanocages (FHn) containing human ferritin heavy chains (FH) and light chains are accurately assembled, leveraging their intrinsic binding with tumor cells and prolonged circulation time in blood, respectively. Further studies reveal that tumor cell uptake is FH density-dependent through active binding with transferrin receptor 1, whereas in vivo tumor accumulation and tissue penetration are found to be correlated to heterogeneous assembly of FHn and vascular permeability of tumors. Densities of 3.7 FH/100 nm

Indexed as

FerritinsNanoparticlesAnimalsCell Line, TumorDisease Models, AnimalFemaleHumansMiceMice, Inbred BALB CNanostructuresNeoplasmsFerritinsferritinheterogeneous nanostructuresprotein nanocagesself‐assemblytumor

Identifiers

PMID38368258
PMCPMC11077646
OpenAlexW4392782743

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.